Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Gross Margin (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Gross Margin for 6 consecutive years, with 60.63% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 337.0% to 60.63% in Q4 2025 year-over-year; TTM through Dec 2025 was 63.7%, a 263.0% increase, with the full-year FY2025 number at 63.7%, up 263.0% from a year prior.
  • Gross Margin was 60.63% for Q4 2025 at PROCEPT BioRobotics, down from 64.81% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 65.35% in Q2 2025 to a low of 42.27% in Q2 2021.
  • A 5-year average of 54.57% and a median of 53.97% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: skyrocketed 7109bps in 2021, then crashed -337bps in 2025.
  • PROCEPT BioRobotics' Gross Margin stood at 44.55% in 2021, then increased by 1bps to 44.9% in 2022, then rose by 9bps to 48.77% in 2023, then soared by 31bps to 64.0% in 2024, then decreased by -5bps to 60.63% in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Gross Margin are 60.63% (Q4 2025), 64.81% (Q3 2025), and 65.35% (Q2 2025).